Soefje SA - Search Results

1

Reducing Cancer Drug Cost: 3-Year Analysis of Automated Dose Rounding in Electronic Health Records.

Shah VS, Irvine C, McWilliams RR, Singh P, Soefje SA. Shah VS, et al. Among authors: soefje sa. JCO Oncol Pract. 2024 Aug 5:OP2300688. doi: 10.1200/OP.23.00688. Online ahead of print. JCO Oncol Pract. 2024. PMID: 39102643

2

Decreasing drug waste, reducing drug costs, and improving workflow efficiency through the implementation of automated chemotherapy dose rounding rules in the electronic health record system.

Shah V, Spence A, Bartels T, Betcher J, Soefje S. Shah V, et al. Am J Health Syst Pharm. 2022 Apr 1;79(8):676-682. doi: 10.1093/ajhp/zxab479. Am J Health Syst Pharm. 2022. PMID: 34940791

3

Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers.

Soefje SA, Carpenter C, Carlson K, Awasthi S, Lin TS, Kaila S, Tarjan D, Kayal N, Kirkup C, Wagner TE, Gray KS, Kumar S. Soefje SA, et al. JCO Oncol Pract. 2023 Apr;19(4):e542-e549. doi: 10.1200/OP.22.00421. Epub 2023 Feb 9. JCO Oncol Pract. 2023. PMID: 36758192 Free PMC article.

4

Impact of Premedication De-Escalation on Incidence of Infusion-Related Reactions With Daratumumab.

Vazirnia D, Del Rio Verduzco A, Soefje SA, Sanders KA, Sandahl TB. Vazirnia D, et al. Among authors: soefje sa. JCO Oncol Pract. 2024 Feb 26:OP2300470. doi: 10.1200/OP.23.00470. Online ahead of print. JCO Oncol Pract. 2024. PMID: 38408288

5

Analysis of Medicare Expenditure for Discarded Infused Cancer Therapeutics From 2017-2020.

Desai A, Xiao A, Smith C, Jensen C, Pritchett J, Soefje S, Durani U, Go R, Scheckel C; Hematology Oncology Outcomes Research Group. Desai A, et al. Mayo Clin Proc. 2023 Dec;98(12):1767-1773. doi: 10.1016/j.mayocp.2023.07.026. Mayo Clin Proc. 2023. PMID: 38043994

6

Evaluation of Burnout in a National Sample of Hematology-Oncology Pharmacists.

Golbach AP, McCullough KB, Soefje SA, Mara KC, Shanafelt TD, Merten JA. Golbach AP, et al. Among authors: soefje sa. JCO Oncol Pract. 2022 Aug;18(8):e1278-e1288. doi: 10.1200/OP.21.00471. Epub 2021 Nov 18. JCO Oncol Pract. 2022. PMID: 34793242

7

Implementing and Optimizing Biosimilar Use at Mayo Clinic.

Jensen CJ, Tichy EM, Lempke MB, Ewald AM, Erickson SJ, Holm MR, Soefje SA. Jensen CJ, et al. Among authors: soefje sa. Mayo Clin Proc. 2022 Jun;97(6):1086-1093. doi: 10.1016/j.mayocp.2022.02.015. Epub 2022 Mar 22. Mayo Clin Proc. 2022. PMID: 35337661

8

Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network.

Booth JP, Kennerly-Shah JM, Kelley LR, Capozzi D, Prescott HA, Soefje SA, Pace MB, Barbour SY, Tizon RF, DeVincenzo S, Carnes CA, Neidecker MV. Booth JP, et al. Among authors: soefje sa. J Oncol Pharm Pract. 2023 Dec;29(8):1907-1914. doi: 10.1177/10781552231157660. Epub 2023 Feb 19. J Oncol Pharm Pract. 2023. PMID: 36803319

9

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding.

Soefje S, Rickabaugh K, Rajkumar R, Wall KP. Soefje S, et al. Int J Pharm Compd. 2021 Nov-Dec;25(6):515-522. Int J Pharm Compd. 2021. PMID: 34807847

10

Development of an innovative delivery system for bacillus Calmette-Guérin bladder administration.

Szewczyk MT, Soefje SA. Szewczyk MT, et al. Among authors: soefje sa. Am J Health Syst Pharm. 2021 Jan 1;78(1):60-64. doi: 10.1093/ajhp/zxaa339. Am J Health Syst Pharm. 2021. PMID: 33091117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters